Table 1.

Clinical benefit with omalizumab therapy.

Strong evidence	Allergic asthma Chronic urticaria
Good evidence	Allergic rhinitis Allergen immunotherapy (inhalants)
Fair evidence	Atopic dermatitis Food allergy Oral immunotherapy (foods) Mast cell disorders
Weak evidence	Eosinophilic gastrointestinal diseases Allergic bronchopulmonary aspergillosis Nasal polyps